Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study ; volume:12 ; number:1 ; day:17 ; month:9 ; year:2014 ; pages:1-2 ; date:9.2014
Pediatric rheumatology ; 12, Heft 1 (17.9.2014), 1-2, 9.2014
- Urheber
-
Van Dijkhuizen, Pieter
Pouw, Juliëtte
Scheuern, Andrea
Hügle, Boris
Hardt, Sven
Ganser, Gerd
Kümmerle-Deschner, Jasmin
Horneff, Gerd
Holzinger, Dirk
Ćalasan, Maja Bulatović
Wulffraat, Nico
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-12-S1-P131
- URN
-
urn:nbn:de:101:1-2019063020174158605380
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Van Dijkhuizen, Pieter
- Pouw, Juliëtte
- Scheuern, Andrea
- Hügle, Boris
- Hardt, Sven
- Ganser, Gerd
- Kümmerle-Deschner, Jasmin
- Horneff, Gerd
- Holzinger, Dirk
- Ćalasan, Maja Bulatović
- Wulffraat, Nico
- SpringerLink (Online service)
Ähnliche Objekte (12)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis